Alignment Healthcare, Inc. (ALHC) stock
ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3038% above fair value
$6.72−0.90 (-11.81%)
Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –
Alignment Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Alignment Healthcare's revenue for the twelve months ending Sep 30, 2026 was $4.94B, up 35.9% year over year. For fiscal 2025 it was $3.95B, up 46.1% from the year before. The highest annual figure on record is $3.95B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.95B | +46.1% |
| FY2024 | Dec 31, 2024 | $2.70B | +48.3% |
| FY2023 | Dec 31, 2023 | $1.82B | +27.2% |
| FY2022 | Dec 31, 2022 | $1.43B | +22.8% |
| FY2021 | Dec 31, 2021 | $1.17B | +21.7% |
| FY2020 | Dec 31, 2020 | $959.22M | +26.7% |
| FY2019 | Dec 31, 2019 | $756.96M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.36B | +36.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.34B | +31.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.24B | +33.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.01B | +44.4% |
| Q3 FY2025 | Sep 30, 2025 | $993.70M | +43.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.02B | +49.0% |
| Q1 FY2025 | Mar 31, 2025 | $926.93M | +47.5% |
| Q4 FY2024 | Dec 31, 2024 | $701.24M | +50.7% |
| Q3 FY2024 | Sep 30, 2024 | $692.43M | +51.6% |
| Q2 FY2024 | Jun 30, 2024 | $681.29M | +47.3% |
| Q1 FY2024 | Mar 31, 2024 | $628.60M | +43.1% |
| Q4 FY2023 | Dec 31, 2023 | $465.39M | +28.6% |
| Q3 FY2023 | Sep 30, 2023 | $456.71M | +26.7% |
| Q2 FY2023 | Jun 30, 2023 | $462.38M | +26.2% |
| Q1 FY2023 | Mar 31, 2023 | $439.16M | +27.1% |
| Q4 FY2022 | Dec 31, 2022 | $361.81M | +21.3% |
| Q3 FY2022 | Sep 30, 2022 | $360.35M | +22.8% |
| Q2 FY2022 | Jun 30, 2022 | $366.47M | +18.6% |
| Q1 FY2022 | Mar 31, 2022 | $345.53M | +29.4% |
| Q4 FY2021 | Dec 31, 2021 | $298.27M | +23.0% |
| Q3 FY2021 | Sep 30, 2021 | $293.47M | +18.4% |
| Q2 FY2021 | Jun 30, 2021 | $308.95M | +26.5% |
| Q1 FY2021 | Mar 31, 2021 | $267.08M | +18.9% |
| Q4 FY2020 | Dec 31, 2020 | $242.41M | – |
| Q3 FY2020 | Sep 30, 2020 | $247.87M | – |
| Q2 FY2020 | Jun 30, 2020 | $244.31M | – |
| Q1 FY2020 | Mar 31, 2020 | $224.63M | – |
See a number that looks wrong?